Mutant Ras proteins regulate several downstream effectors; many of which are aberrantly activated during cancer progression and the main signalling pathways mediated by them are the RAF/MEK/ERK kinase pathway and the PI3K/AKT signalling pathway. This evidence concerns the gene MAP2K7 and cancer.